(1)
Uncovering Aristolochic Acid–Driven Mutational Signatures and Novel Biomarkers InPrimary Hepatic Angiosarcoma for Targeted Therapeutic Development. PAJHPS 2026, 2 (1). https://doi.org/10.64261/55166d57.